Factors Predicting Hostility in Outpatients With Schizophrenia 36-Month Results From the SOHO Study

被引:9
|
作者
Ochoa, Susana [1 ]
Suarez, David [1 ,2 ]
Novick, Diego [3 ]
Arranz, Belen [1 ]
Roca, Mercedes [1 ]
Bano, Vicente [1 ]
Maria Haro, Josep [1 ,4 ]
机构
[1] CIBERSAM, Barcelona 08830, Spain
[2] CIBERSAM, Fundacio St Joan de Deu, Barcelona 08830, Spain
[3] Eli Lilly & Co, Hlth Outcomes Res, Windlesham, Surrey, England
[4] Univ Barcelona, Fac Med, Barcelona 7, Spain
关键词
Schizophrenia; hostility; psychopathology; medication compliance; extrapyramidal effects; VIOLENT BEHAVIOR; OVERT AGGRESSION; INPATIENTS; CLOZAPINE; SYMPTOMS; RISPERIDONE; OLANZAPINE; DISORDER;
D O I
10.1097/NMD.0b013e31829480b0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This analysis explored the prevalence, incidence, and predictors of hostility in the European Schizophrenia Outpatient Health Outcomes (EU-SOHO) study. Data were collected at baseline and up to 36 months on the presence of hostility, clinical course and severity, medication compliance, side effects, substance/alcohol abuse, and being a crime survivor. Regression models were fitted to test the association between predictors and the presence of hostility. Hostility prevalence in the 6 months before baseline was 27.9%, and the incidence at 3 years was 14.0%. Variables related to hostility during follow-up were age, male sex, alcohol/substance abuse, tardive dyskinesia, extrapyramidal symptoms, cognitive impairment, noncompliance, and hospitalization. Being a crime survivor, being married, not living independently, and not being in paid employment were associated with hostility at baseline. Clinical and social variables are related to hostility in schizophrenia. Extrapyramidal symptoms and tardive dyskinesia, alcohol/substance abuse, cognitive impairment, medication noncompliance, and hospitalizations are predictors of future hostility.
引用
收藏
页码:464 / 470
页数:7
相关论文
共 50 条
  • [11] Subthalamic Stimulation Improves Quality of Sleep in Parkinson Disease: A 36-Month Controlled Study
    Jost, Stefanie T.
    Chaudhuri, K. Ray
    Ashkan, Keyoumars
    Loehrer, Philipp A.
    Silverdale, Monty
    Rizos, Alexandra
    Evans, Julian
    Petry-Schmelzer, Jan Niklas
    Barbe, Michael T.
    Sauerbier, Anna
    Fink, Gereon R.
    Visser-Vandewalle, Veerle
    Antonini, Angelo
    Martinez-Martin, Pablo
    Timmermann, Lars
    Dafsari, Haidar S.
    JOURNAL OF PARKINSONS DISEASE, 2021, 11 (01) : 323 - 335
  • [12] Predictive Factors for Persistent Use and Compliance of Immediate-Release Methylphenidate: A 36-Month Naturalistic Study
    Atzori, Paola
    Usala, Tatiana
    Carucci, Sara
    Danjou, Fabrice
    Zuddas, Alessandro
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (06) : 673 - 681
  • [13] Endometrial Cryoablation for the Treatment of Heavy Menstrual Bleeding: 36-Month Outcomes from the CLARITY Study
    Curlin, Howard L.
    Anderson, Ted L.
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2022, 14 : 1083 - 1092
  • [14] Long-term, naturalistic treatment with olanzapine, risperidone, quetiapine, or haloperidol monotherapy: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study
    Lee, Phil
    Kim, Chul Eung
    Kim, Chang Yoon
    Lin, Wei-Wen
    Habil, Hussain
    Dyachkova, Yulia
    Mcbride, Margaret
    Dossenbach, Martin
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2008, 12 (03) : 215 - 227
  • [15] Factors associated with achieving minimally symptomatic status by patients with schizophrenia: results from the 3-year intercontinental schizophrenia outpatients health outcomes study
    Treuer, T.
    Martenyi, F.
    Saylan, M.
    Dyachkova, Y.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (06) : 697 - 706
  • [16] The intercontinental schizophrenia outpatient health outcomes study (IC-SOHO):: Initial 6 month findings of the sample in Latin America
    Brunner, E
    Gargoloff, P
    Caro, O
    González, C
    Landa, E
    González, CH
    Barahonal, A
    Soria, D
    Tamayo, J
    Rovnerlo, J
    Adrianzen, C
    Silva, H
    Hodge, A
    O'Halloran, R
    Assunçao, SSM
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2006, 34 (01): : 16 - 27
  • [17] Do Premenopausal Women with Major Depression Have Low Bone Mineral Density? A 36-Month Prospective Study
    Cizza, Giovanni
    Mistry, Sima
    Nguyen, Vi T.
    Eskandari, Farideh
    Martinez, Pedro
    Torvik, Sara
    Reynolds, James C.
    Gold, Philip W.
    Sinai, Ninet
    Csako, Gyorgy
    PLOS ONE, 2012, 7 (07):
  • [18] Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: Results from a six-month prospective, multinational, observational study
    Treuer, Tamas
    Hoffmann, Vicki Poole
    Chen, Antony Kuang-Peng
    Irimia, Victoria
    Ocampo, Magdalena
    Wang, Gang
    Singh, Pritibha
    Holt, Susanna
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2009, 10 (04) : 729 - 740
  • [19] Effectiveness and tolerability of schizophrenia treatment in Central and Eastern Europe: results after 1 year from a prospective, observational study (IC-SOHO)
    Treuer, Tamas
    Anders, Martin
    Bitter, Istvan
    Dobre, Gheorghe
    Pecenak, Jan
    Dyachkova, Yulia
    Harrison, Gavan
    O'Mahoney, John
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2006, 10 (02) : 78 - 90
  • [20] Incidence and characteristics of remission in schizophrenic patients: analysis of the results of the three-year SOHO study in Italy (Schizophrenia Outpatients Health Outcomes)
    Brugnoli, R.
    Novick, D.
    Haro, J. Maria
    Suarez, D.
    Rossi, A.
    Frediani, S.
    JOURNAL OF PSYCHOPATHOLOGY, 2008, 14 (03): : 243 - 251